Lessons Learned: What to Know About Producing Personalized Therapies

In the second of our three-series podcast with Vineti, Chief Commercial Officer Joe DePinto provides a first-hand look at what it takes to actually produce personalized therapies at scale based on the work that Vineti is doing with companies in this space. He provides key lessons learned that span the developmental process from the clinical phase to commercial.

DePinto offers his take on the areas he sees companies struggle most with and what any company considering developing personalized therapies would need to know to be successful. And that includes what parts of the process may evolve in the future.

Listen below or catch up on the first part of the series at: https://www.pm360online.com/vineti1.

Featuring: Joe DePinto, Chief Commercial Officer, Vineti

Sign up to listen to the podcast as well as receive an alert when the next installment in the series comes out.

As a teaser, we will be speaking with Phil Calvin, CTO, Vineti about how to evolve and mature the use technology within biotech and pharma, including the use of the cloud, AI, blockchain, and more.